Vaxxinity Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Mei Hu

Chief executive officer

US$1.4m

Total compensation

CEO salary percentage22.6%
CEO tenure10.5yrs
CEO ownership4.4%
Management average tenureless than a year
Board average tenure2.9yrs

Recent management updates

Recent updates

A Look At The Intrinsic Value Of Vaxxinity, Inc. (NASDAQ:VAXX)

Jan 08
A Look At The Intrinsic Value Of Vaxxinity, Inc. (NASDAQ:VAXX)

Vaxxinity initiates rolling submission for its COVID-19 shot with UK's drug regulator

Sep 12

CEO Compensation Analysis

How has Mei Hu's remuneration changed compared to Vaxxinity's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$1mUS$308k

-US$57m

Sep 30 2023n/an/a

-US$66m

Jun 30 2023n/an/a

-US$72m

Mar 31 2023n/an/a

-US$75m

Dec 31 2022US$532kUS$400k

-US$75m

Sep 30 2022n/an/a

-US$103m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

-US$123m

Dec 31 2021US$13mUS$400k

-US$137m

Sep 30 2021n/an/a

-US$102m

Jun 30 2021n/an/a

-US$88m

Mar 31 2021n/an/a

-US$68m

Dec 31 2020US$348kUS$335k

-US$40m

Compensation vs Market: Mei's total compensation ($USD1.36M) is above average for companies of similar size in the US market ($USD683.22K).

Compensation vs Earnings: Mei's compensation has increased whilst the company is unprofitable.


CEO

Mei Hu (41 yo)

10.5yrs

Tenure

US$1,360,331

Compensation

Ms. Mei Mei Hu, J.D., serves as Chief Executive Officer of Vaxxinity, Inc. and has been its President has been its Director since 2014 and served as its President until June 2022. She Co-Founded Vaxxinity,...


Leadership Team

NamePositionTenureCompensationOwnership
Louis Reese
Co-Founder & Executive Chairman of the Board9.8yrsUS$1.29m3.13%
$ 991.3k
Mei Hu
Co-Founderno dataUS$1.36m4.35%
$ 1.4m
Sumita Ray
Chief Legalless than a yearUS$823.41kno data
Jason Pesile
Chief Accounting Officerless than a yearno datano data
Jean-Cosme Dodart
Chief Scientific Officerless than a yearno datano data
Mark Joinnides
Chief of Staffno datano datano data
Manal Morsy
Chief Regulatory Officerless than a yearno datano data

0.5yrs

Average Tenure

46yo

Average Age

Experienced Management: VAXX's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Louis Reese
Co-Founder & Executive Chairman of the Board9.8yrsUS$1.29m3.13%
$ 991.3k
Mei Hu
Co-Founder10.5yrsUS$1.36m4.35%
$ 1.4m
George Hornig
Independent Director2.5yrsUS$264.15k0%
$ 0
Peter Diamandis
Non-Employee Independent Director3.3yrsUS$233.94k1.59%
$ 504.0k
Eric Reiman
Member of Scientific Advisory Boardno datano datano data
Jeffrey Cummings
Member of Scientific Advisory Boardno datano datano data
Stanley Plotkin
Member of Scientific Advisory Boardno datano datano data
Gabrielle Toledano
Independent Director1.4yrsUS$259.99k0%
$ 0
Richard Mohs
Member of Scientific Advisory Boardno datano datano data
Brad Boeve
Member of Scientific Advisory Boardno datano datano data
Nick Fox
Member of Scientific Advisory Boardno datano datano data
Landon Ogilvie
Lead Independent Director1.4yrsUS$270.62k0.026%
$ 8.2k

2.9yrs

Average Tenure

60yo

Average Age

Experienced Board: VAXX's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.